Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

During the past few years, scientific journals have published an increasing number of groundbreaking articles about the efficacy of employing T-cell bispecific antibodies (TRBAs) in cancer immunotherapy. The research is encouraging: More than 50 bispecific antibodies are currently in clinical trials. Below are links to recent scholarship and resources that can help practices better serve their patients …
This accelerated delivery platform improves clinic workflow and speeds up breast cancer diagnosis and treatment planning.
Other Events Registration is Open for the 2023 ASH Meeting on Hematologic Malignancies September 8-9, 2023 Chicago, IL Looking to connect with colleagues and hear hematology experts present the latest in the management of hematologic malignancies? Join us for the ASH Meeting on Hematologic Malignancies, taking place September 8-9, 2023, in Chicago! Leaders in the field of hematology will present …
To help you prepare and submit your poster abstract for the ACCC 41st National Oncology Conference, we have provided comprehensive guidelines below. Please read these instructions carefully to ensure your submission meets all necessary criteria. This document includes important information on: Poster dimensions Content layout and organization Font sizes and styles Transporting and …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. TxSCO ONCOLOGY DRUG NEWSLETTER J U LY 2 0 2 4 FDA APPROVALS Lisocabtagene maraleucel (liso-cel; Breyanzi) The FDA has approved the chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel (liso-cel; Breyanzi) for …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. TACOS ONCOLOGY DRUG NEWSLETTER J U LY 2 0 2 4 FDA APPROVALS Lisocabtagene maraleucel (liso-cel; Breyanzi) The FDA has approved the chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel (liso-cel; Breyanzi) for …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. NCOA ONCOLOGY DRUG NEWSLETTER J U LY 2 0 2 4 FDA APPROVALS Lisocabtagene maraleucel (liso-cel; Breyanzi) The FDA has approved the chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel (liso-cel; Breyanzi) for …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. SCOS ONCOLOGY DRUG NEWSLETTER J U LY 2 0 2 4 FDA APPROVALS Lisocabtagene maraleucel (liso-cel; Breyanzi) The FDA has approved the chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel (liso-cel; Breyanzi) for …
ACT-Lexicon-2016
Highlights from ACCC's 18th Annual Meeting Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Highlights from ACCC's 18th Annual Meeting To cite this article: (1992) Highlights from …
NCCCP-Navigation-Matrix-Tool
Hubert H. Humphrey Cancer Center Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Hubert H. Humphrey Cancer Center Specialized Programs for Lung Cancer Patients To cite this …
ICLIO e-Course: A Washington Perspective ICLIO e-Course: A Washington Perspective Dan Todd Principal, Dan Todd Strategy June 1,2016 accc-iclio.org Dan Todd 1325 G Street, NW – Suite 500 Washington, D.C. 20005 202.352.7761 dan@toddstrategy.com 2 © 2016 ICLIO and Todd Strategy Learning Objectives 3 Deconstructing …
One of your initial appointments will be with our Cancer Care Navigator, who will be there to guide you and your family through the full spectrum of oncology services, thus allowing more time to focus on recovery and healing. What is a Cancer Care Navigator? A Cancer Care Navigator is an experienced registered nurse who specializes in the care and support of cancer …
The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the multidisciplinary cancer team. ACCC is a powerful network of 24,000 cancer care professionals from 2,100 hospitals and practices nationwide. ACCC is recognized as the premier provider of resources for the entire oncology care team. For more information, visit accc-cancer.org or call …
JA11-Editor
MUSC Center for Telehealth Shared Decision Making for Financial Advocates ACCC Financial Advocacy Network Summit August 16, 2018 Downtown Washington DC Telehealth Overview and Trends (advisory committee)(advisory committee) Disclosure I have no relevant disclosures or conflicts of interest Objectives The learner will - › Be able to articulate …
media_CongressionalLetter_052907
more online @ accc-cancer.org Psychosocial Oncology Services During COVID-19 Jeffrey Kendall, PsyD, LP, shares how patients with cancer are dealing with the “new normal,” and how oncology social workers, psychologists, and psychiatrists are working to help them through this unprecedented time. Go to accc-cancer.org/COVID-19, then “Publications.” Join the COVID-19 Discussion …